Home › Calculator › TEVJF Dividend Calculator 2026
TEVJF Dividend DRIP Calculator 2026
5.41% YieldHealthcareTeva Pharmaceutical Industries Limited · OTC
Price: $37.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When TEVJF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your TEVJF snowball 📈
$10,000 in TEVJF → $15.9K in 10 years · $73.91/month
About Teva Pharmaceutical Industries Limited (TEVJF) — Dividend Analysis 2026
Teva Pharmaceutical Industries Limited operates as a global pharmaceutical enterprise, engaging in the research, production, marketing, and distribution of generic medications, specialized pharmaceutical products, and biopharmaceuticals. The company's reach extends across North America, Europe, and various other international markets. Its extensive product offerings include sterile formulations, hormonal therapies, highly potent drugs, and cytotoxic compounds, available in a wide array of dosage forms. These delivery methods encompass oral tablets and capsules, injectable solutions, inhaled preparations, liquid medicines, transdermal patches, and topical ointments and creams. Additionally, Teva develops, manufactures, and commercializes active pharmaceutical ingredients. The company's primary therapeutic focus areas are the central nervous system, pain management, respiratory conditions, and oncology. Within its central nervous system portfolio, key products feature Copaxone, prescribed for relapsing multiple sclerosis; AJOVY, utilized for migraine prevention; and AUSTEDO, indicated for the treatment of tardive dyskinesia and Huntington's disease-associated chorea. In the respiratory sector, Teva provides medications such as ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick, all aimed at managing asthma and chronic obstructive pulmonary disease. Its oncology division includes products like Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Furthermore, Teva Pharmaceutical Industries Limited maintains a collaborative agreement with MedinCell to develop and commercialize various long-acting injectable products, including a risperidone suspension designed for individuals with schizophrenia. Established in 1901, the company's corporate headquarters are located in Tel Aviv-Yafo, Israel.
Compare TEVJF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full TEVJF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open TEVJF position with:
🌍 TEVJF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold TEVJF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 5.41% | 2.61% | $541 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 4.60% | 1.80% | $460 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 4.33% | 1.53% | $433 / yr |
| 🇬🇧 UK ISA | 0% | 5.41% | 2.61% | $541 / yr |
| 🇬🇧 UK Taxable | 8.75% | 4.94% | 2.14% | $494 / yr |
| 🇨🇦 TFSA | 0% | 5.41% | 2.61% | $541 / yr |
| 🇨🇦 CA Taxable | 25% | 4.06% | 1.26% | $406 / yr |
| 🇦🇺 Super (pension) | 15% | 4.60% | 1.80% | $460 / yr |
| 🇦🇺 AU Taxable | 30% | 3.79% | 0.99% | $379 / yr |
| 🇩🇪 DE Taxable | 26.375% | 3.98% | 1.18% | $398 / yr |
| 🇫🇷 FR Taxable | 30% | 3.79% | 0.99% | $379 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 TEVJF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 TEVJF Dividend Payment Schedule
TEVJF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 TEVJF vs Healthcare Benchmarks
How TEVJF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for TEVJF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ TEVJF Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2023-11-20 | 253,968 | — | — | ||
| A-Award | 2023-11-15 | 33,482 | — | — | ||
| A-Award | 2023-11-15 | 33,482 | — | — | ||
| Other | 2023-10-13 | 17,505 | $34.70 | $607.4K | ||
| Other | 2023-10-13 | 7,010 | $16.99 | $119.1K | ||
| Other | 2023-10-13 | 31,075 | — | — | ||
| Other | 2023-10-13 | 27,501 | $19.16 | $526.9K | ||
| Other | 2023-10-13 | 12,754 | $53.50 | $682.3K | ||
| Other | 2023-10-13 | 8,755 | $28.98 | $253.7K | ||
| Other | 2023-10-13 | 12,753 | $60.21 | $767.9K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where TEVJF earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the TEVJF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Teva Pharmaceutical Industries Limited (TEVJF) is currently trading at $37.00, trading near its 52-week high. The current dividend yield is 5.41% based on an annual payout of $2.00 per share.
TEVJF (Teva Pharmaceutical Industries Limited) — 5.41% Dividend Yield Analysis
Teva Pharmaceutical Industries Limited (TEVJF) is a healthcare stock currently trading at $37.00 with a dividend yield of 5.41%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.